100
Participants
Start Date
January 1, 2012
Primary Completion Date
November 9, 2020
Study Completion Date
November 9, 2020
preoperative infusion of levosimendan
the study group will consist of patients who have received a continuous infusion of levosimendan 0.1 μg/kg/min for 24 hours before cardiac surgery
no preoperative infusion of levosimendan
the control group will consist of patients who proceeded to the cardiac operation without any infusion for 24 hours preoperatively
Onassis Cardiac Surgery Center, Athens
Aretaieion University Hospital
OTHER